SCHEMBL17124151

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3244621	0.92	EGFR (1.00)	EGFRABCG2ERBB2
	SCHEMBL30552991	0.92	EGFR (1.00)	EGFRABCG2ERBB2
	SCHEMBL4354577	0.86	ABCG2 (1.00)	EGFRABCG2MEN1KMT2AKDM4E
	SCHEMBL4587672	0.84	ALK (0.79)	EGFRABCG2MAPK1MEN1MAPT
	SCHEMBL18349251	0.83	EGFR (0.77)	EGFRABCG2MEN1MAPTHTT
	SCHEMBL1192454	0.82	EGFR (1.00)	EGFRABCG2MAPK1MEN1MAPT
	SCHEMBL8871504	0.82	EGFR (0.76)	EGFRABCG2MAPK1MAPTHTT
	SCHEMBL8871973	0.82	EGFR (0.83)	EGFRABCG2MEN1MAPTHTT
	SCHEMBL4587413	0.82	EGFR (0.83)	EGFRABCG2MEN1MAPTHTT
	SCHEMBL2099212	0.80	ABCG2 (1.00)	EGFRABCG2MAPK1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.